CEO Michael Kauffman sold $112K of Karyopharm Therapeutics Inc.

Sold$111,683

$14.89Price

7,500Shares

−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Oct 12. Filed Wed, Oct 14, 1:56 PM ET, during the session. Not investment advice.